Holen Sie sich die Stockscreener-App
25.04
0.00%
0.00
Handel nachbörslich:
25.08
0.04
+0.16%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer Slashes Guidance, Faces Patent Cliff—Is the Worst Yet to Come? - Smartkarma
Can Pfizer Inc. stock hit analyst price targetsQuarterly Market Summary & Fast Gaining Stock Reports - Улправда
Pfizer’s birth control injection has a new safety label, reflecting potential brain tumors - Medical Marketing and Media
Better Buy in 2026: Pfizer or Eli Lilly? - AOL.com
How Pfizer Inc. stock reacts to Fed rate cutsWeekly Market Report & Consistent Income Trade Recommendations - Улправда
Pfizer’s New Liver Cancer Trial Signals a Longer-Term Oncology Upside for PFE - TipRanks
White House Readies Drug Price Deals With AbbVie, Novartis, Roche - Benzinga
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts - The AI Journal
Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry - Benzinga
Federal lawsuit accuses Teva of colluding with Pfizer to delay releasing generic drugs - The Business Journals
Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts - ts2.tech
Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun - Benzinga
Fiduciary Alliance LLC Has $3.70 Million Position in Pfizer Inc. $PFE - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.43 - simplywall.st
Czech National Bank Purchases 54,306 Shares of Pfizer Inc. $PFE - MarketBeat
Gradient Investments LLC Has $4.09 Million Stake in Pfizer Inc. $PFE - MarketBeat
Astellas, Pfizer Combo Shows Survival Gains In Early-Stage Bladder Cancer Trial - marketscreener.com
Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday - ts2.tech
Pfizer CEO Says US Vaccine Policy Changes A Political ‘Anomaly’ - Citeline News & Insights
Pfizer (NYSE:PFE) Trading Down 1.9%Time to Sell? - MarketBeat
Pfizer Inc (PFE) rating steady amid neutral market outlook and pipeline progress - MSN
Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress - Finviz
Analysts’ Top Healthcare Picks: Pfizer (PFE), Novan (NOVN) - The Globe and Mail
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025) - ts2.tech
Pfizer: Ignoring The Dead Cat Bounce (NYSE:PFE) - Seeking Alpha
Pfizer: 2026 Feels Like Another Lost Year After Yesterday's Guidance Update (NYSE:PFE) - Seeking Alpha
Company News for Dec 17, 2025 - The Globe and Mail
Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future? - The Globe and Mail
Pfizer, Merck Are Boring Again: 2026 Investors Are Circling BackMerck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now - Finviz
Guggenheim maintains Buy rating on Pfizer stock, sets $35 price target - Investing.com Canada
Pfizer Stock (PFE) Slips After 2026 Outlook: Guidance, Analyst Forecasts, Dividend Update, and Key Catalysts to Watch on Dec. 17, 2025 - ts2.tech
Quintet Private Bank Europe S.A. Raises Position in Pfizer Inc. $PFE - MarketBeat
Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda - Seeking Alpha
Pfizer says phase 3 EV-304 clinical trial meets primary endpoint - marketscreener.com
Pfizer shares slide on pessimistic projections - The Pharma Letter
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance - BioSpace
Wolfe Research Adjusts Price Target on Pfizer to $24 From $25, Maintains Underperform Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on Pfizer to $27 From $28, Maintains Equalweight Rating - marketscreener.com
Pfizer stock price target lowered to $24 at Wolfe Research on underperformance - Investing.com Canada
Thrivent Financial for Lutherans Increases Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock Fell 3.4% Yesterday On Modest 2026 Outlook - TIKR.com
Corient Private Wealth LLC Sells 179,789 Shares of Pfizer Inc. $PFE - MarketBeat
Assenagon Asset Management S.A. Purchases 3,722,531 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Stock on the Edge: 3 Threats You Need to Know - Trefis
Pfizer : Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance Transcript - marketscreener.com
Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts - ts2.tech
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast - Yahoo Finance
Pfizer's Oncology and Obesity Pipelines Support a Narrow Moat Despite Looming Patent Expirations - Morningstar
Pfizer Stock After Hours Today (Dec. 16, 2025): PFE Drops on 2026 Outlook—What to Know Before the Market Opens Dec. 17 - ts2.tech
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Pfizer (NYSE:PFE) Stock Price Down 3.3% After Analyst Downgrade - MarketBeat
Pfizer Stands By Vaccines Investment Despite Political ‘Anomaly’ - Citeline News & Insights
Tepid 2026 outlook dents Pfizer shares - Yahoo Finance
Pfizer ’26 Guidance Puts Emphasis On The Long Term For A Return To Growth - Citeline News & Insights
Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO - Yahoo Finance
PFIZER INC : Jefferies reiterates its Buy rating - marketscreener.com
Pfizer Q4 2026 Financial Guidance (NYSE:PFE) 2025-12-16 - Seeking Alpha
Transcript : Pfizer Inc., 2026 Guidance/Update Call, Dec 16, 2025 - marketscreener.com
Market movers: Circle, Pfizer, Reconnaissance Energy Africa... - Proactive Investors
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector - FinancialContent
Pfizer faces challenging years on fading COVID sales, margin pressure - Reuters
Pfizer forecasts 2026 profit below expectations on lower COVID product sales - WKZO
Pfizer leads COVID-19 vaccine peers lower after revamped guidance - Seeking Alpha
0.09%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):